| Datum | Zeit | Quelle | Überschrift | Symbol | Firma |
| 09/02/2024 | 01h22 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
| 19/10/2023 | 22h48 | Edgar (US Regulatory) | Form 15-12G - Securities registration termination [Section 12(g)] | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
| 12/10/2023 | 06h15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
| 11/10/2023 | 16h17 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
| 11/10/2023 | 16h12 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
| 11/10/2023 | 16h05 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
| 11/10/2023 | 16h02 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
| 11/10/2023 | 15h27 | Edgar (US Regulatory) | Form POS AM - Post-Effective amendments for registration statement | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
| 11/10/2023 | 15h27 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
| 11/10/2023 | 15h24 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
| 11/10/2023 | 15h22 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
| 11/10/2023 | 15h22 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
| 11/10/2023 | 15h22 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
| 11/10/2023 | 15h22 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
| 11/10/2023 | 15h21 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
| 11/10/2023 | 15h20 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
| 11/10/2023 | 15h19 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
| 11/10/2023 | 15h19 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
| 11/10/2023 | 14h56 | Edgar (US Regulatory) | Form SC 14D9/A - Solicitation, recommendation statements: [Amend] | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
| 11/10/2023 | 14h31 | Edgar (US Regulatory) | Form SC TO-T/A - Tender offer statement by Third Party: [Amend] | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
| 11/10/2023 | 14h17 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
| 11/10/2023 | 14h00 | PR Newswire (US) | HARMONY BIOSCIENCES COMPLETES ACQUISITION OF ZYNERBA PHARMACEUTICALS AND EXPANDS PIPELINE | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
| 04/10/2023 | 23h29 | Edgar (US Regulatory) | Form SC 14D9/A - Solicitation, recommendation statements: [Amend] | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
| 04/10/2023 | 22h05 | GlobeNewswire Inc. | Important Information for Zynerba Pharmaceuticals Stockholders to Tender Shares for the Harmony Transaction: Process and Instructions | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
| 29/09/2023 | 15h00 | GlobeNewswire Inc. | Zynerba Pharmaceuticals Stockholders Reminded to Tender Shares Before 5:00 PM New York City Time, on Tuesday October 10, 2023 | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
| 27/09/2023 | 14h25 | Edgar (US Regulatory) | Form SC 14D9/A - Solicitation, recommendation statements: [Amend] | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
| 27/09/2023 | 14h12 | Edgar (US Regulatory) | Form SC TO-T/A - Tender offer statement by Third Party: [Amend] | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
| 27/09/2023 | 14h00 | PR Newswire (US) | HARMONY BIOSCIENCES ANNOUNCES EXTENSION OF TENDER OFFER TO ACQUIRE ZYNERBA PHARMACEUTICALS, INC. | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
| 15/09/2023 | 14h00 | Edgar (US Regulatory) | Form SC 14D9/A - Solicitation, recommendation statements: [Amend] | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
| 14/09/2023 | 22h59 | Edgar (US Regulatory) | Form SC TO-T/A - Tender offer statement by Third Party: [Amend] | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |